The Effect of Molecular Hydrogen on Functional States of Erythrocytes in Rats with Simulated Chronic Heart Failure.
Anna Vyacheslavovna Deryugina, Darya Andreevna Danilova, Vladimir Viktorovich Pichugin, Yurii Dmitrievich Brichkin · Life (Basel, Switzerland) · 2023
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
In rats, on the 14th day, aggregation in the group with multiple exposures to H₂ was restored to the values of the intact group; with a single exposure, aggregation also decreased, while in the control group this indicator exceeded the values of the intact group by 69% ( Figure 2 ). These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.
What the Findings Mean
H2HUBB reviewed how inhaled hydrogen gas affected the outcomes measured in rats. On the 14th day, aggregation in the group with multiple exposures to H₂ was restored to the values of the intact group; with a single exposure, aggregation also decreased, while in the control group this indicator exceeded the values of the intact group by 69% ( Figure 2 ).
What the Researchers Studied
The researchers studied rats. The study used a preclinical animal experiment. The comparison condition was control condition or baseline measurements.
What Effects Did Molecular Hydrogen Have?
Source-reported hydrogen concentration: 2% source-reported H₂ gas concentration; Source-reported hydrogen exposure: 2% source-reported H₂ gas concentration; reported treatment duration: 40 min. On the 14th day, aggregation in the group with multiple exposures to H₂ was restored to the values of the intact group; with a single exposure, aggregation also decreased, while in the control group this indicator exceeded the values of the intact group by 69% ( Figure 2 ). The authors concluded that in conclusion, according to the results obtained, it can be said that the use of H₂ has a beneficial effect on the surface charge, metabolism and aggregation of red blood cells, which improves microcirculation and oxygen transport function of blood and can be effective in the treatment of CHF. Molecular hydrogen has an anti-inflammatory and cardioprotective effect, which is associated with its antioxidant properties.
Why These Findings Matter
These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.
How Strong Is This Evidence?
This is preclinical animal evidence from a preclinical animal experiment. It is most informative for the disease model, mechanisms, biomarkers, and outcomes directly measured in the study.
Technical Study Details
H2HUBB classifies this publication as animal study with preclinical animal evidence. The research population or model was rats. The study used a preclinical animal experiment. The hydrogen delivery method was inhaled hydrogen gas. The source-reported hydrogen concentration was 2% source-reported H₂ gas concentration. The reported treatment duration was 40 min.
Limitations and Safety
No separate limitations or safety findings were identified in the current-study source text available to H2HUBB.
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.